Invention Grant
- Patent Title: Pyrazolyl quinoxaline kinase inhibitors
- Patent Title (中): 吡唑基喹喔啉激酶抑制剂
-
Application No.: US13643741Application Date: 2011-04-28
-
Publication No.: US08895601B2Publication Date: 2014-11-25
- Inventor: Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Christopher Norbert Johnson , Steven John Woodhead , David Charles Rees , Laurence Anne Mevellec , Patrick René Angibaud , Eddy Jean Edgard Freyne , Timothy Pietro Suren Perera , Ronaldus Arnodus Hendrika Joseph Gilissen , Berthold Wroblowski , Jean Fernand Armand Lacrampe , Alexandra Papanikos , Oliver Alexis Georges Querolle , Elisabeth Thérèse Jeanne Pasquier , Isabelle Noëlle Constance Pilatte , Pascal Ghislain André Bonnet , Werner Constant Johan Embrechts , Rhalid Akkari , Lieven Meerpoel
- Applicant: Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Christopher Norbert Johnson , Steven John Woodhead , David Charles Rees , Laurence Anne Mevellec , Patrick René Angibaud , Eddy Jean Edgard Freyne , Timothy Pietro Suren Perera , Ronaldus Arnodus Hendrika Joseph Gilissen , Berthold Wroblowski , Jean Fernand Armand Lacrampe , Alexandra Papanikos , Oliver Alexis Georges Querolle , Elisabeth Thérèse Jeanne Pasquier , Isabelle Noëlle Constance Pilatte , Pascal Ghislain André Bonnet , Werner Constant Johan Embrechts , Rhalid Akkari , Lieven Meerpoel
- Applicant Address: GB Cambridge
- Assignee: Astex Therapeutics Ltd
- Current Assignee: Astex Therapeutics Ltd
- Current Assignee Address: GB Cambridge
- Agency: Heslin, Rothenberg Farley & Mesiti P.C.
- Priority: GB1007286.6 20100430
- International Application: PCT/GB2011/050851 WO 20110428
- International Announcement: WO2011/135376 WO 20111103
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/10 ; C07D231/12 ; C07D405/14 ; C07D403/04 ; C07D487/08 ; C07D413/14 ; C07D403/14 ; C07D409/14
Abstract:
The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20130072457A1 PYRAZOLYL QUINAZOLINE KINASE INHIBITORS Public/Granted day:2013-03-21
Information query
